Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin‐angiotensin‐aldosterone system

The effect of recombinant erythropoietin (rhEPO) on renal and systemic hemodynamics was evaluated in a randomized double‐blinded, cross‐over study. Sixteen healthy subjects were tested with placebo, or low‐dose rhEPO for 2 weeks, or high‐dose rhEPO for 3 days. Subjects refrained from excessive salt...

Descripción completa

Detalles Bibliográficos
Autores principales: Aachmann‐Andersen, Niels J., Christensen, Soren J., Lisbjerg, Kristian, Oturai, Peter, Johansson, Pär I., Holstein‐Rathlou, Niels‐Henrik, Olsen, Niels V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835499/
https://www.ncbi.nlm.nih.gov/pubmed/29504258
http://dx.doi.org/10.14814/phy2.13573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835499/
https://www.ncbi.nlm.nih.gov/pubmed/29504258
http://dx.doi.org/10.14814/phy2.13573

Ejemplares similares